Krka scored 50 out of 100 in the 2023 S&P CSA, with a score of 60 in the governance criteria, 42 in the environmental criteria, and 41 in the social criteria, the company said in a filing with the Ljubljana Stock Exchange on Friday.
The pharmaceuticals producer also obtained a modelled S&P Global ESG Score of 52, it said.
The S&P CSA is an annual evaluation of companies’ sustainability practices. It focuses on sustainability criteria that are both industry-specific and financially material.